Directors in each research area
The directors have been appointed to coordinate each research area. Through discussions, they assign a mentor to individual young researchers to set up a support system from the early phase of research.
Chair
Yousuke Uchitomi
Chief Director
Let’s resolve routine clinical questions as they are. Encountering a question for the “first time” is a given. What is needed is enthusiasm rather than experience.
Thus, why don’t you try to resolve the question in front of you.
I am involved in research on clinical intervention for behavioral changes related to reducing psychological burden and promoting communication between patients and medical professionals. I assist in resolving issues that arise during routine clinical practice related to care and support that differ from pharmacotherapy in the field of supportive, palliative, and psychological care for disease prevention and early detection. The scope is from cancer diagnosis to end-of-life, and survivorship for children and the adolescent and young adult (AYA) generation through to older patients. Please feel free to contact me at any time.
Director
I was appointed as a director owing to my involvement in clinical research, including psychosocial intervention. Anyone involved in research initially experiences the sense that they are encountering everything for the first time. I would like to offer support to inexperienced and non-physician staff.
I am a gynecological oncologist. I studied cancer pain independently when I was a trainee doctor 25 years ago, when palliative care was not widely practiced, which later led me to research supportive care. I wanted to help my patients who were suffering from adverse drug reactions (in my patients’ case, it was chemotherapy-induced nausea and vomiting), so I verified my bedside treatment with retrospective and phase II studies. Despite having no experience, unlike doctors with proven track records, I was suddenly granted Japan Agency for Medical Research and Development (AMED) research funding at the very beginning of my research journey, and I had the opportunity of conducting a randomized controlled trial (RCT) with Dr. Hashimoto, a J-SUPPORT director. Therefore, in that sense, I hope that I am a staff member that all the young, inexperienced researchers should feel at ease consulting with, which I hope will lead to collaborative discussions and result in successful research outcomes.
I am a medical oncologist at the Department of Breast Oncology, Saitama Medical University International Medical Center. My area of expertise is supportive care for anticancer treatment. It is widely recognized that a surgeon’s competency during surgery affects both treatment outcomes and complication rate. Meanwhile, expertise and competency (including communication) also affect treatment outcomes and the rate of adverse drug reactions in anticancer treatment. I provide support to research on supportive and palliative care, to maximize the efficacy and safety of treatment. The first step of research is having a sense of “wanting to reduce patient suffering.”
I am a psychiatrist at Shimane University. Recently, psychology departments, especially in general hospitals, have come to serve a role in providing support to patients experiencing the distress and pain associated with cancer and other various diseases, not only psychological diseases. One of the aims of this change is the development and dissemination of new and better supportive methods. I am looking forward to working with everyone.
My name is Shimazu from the National Cancer Center, and I am in charge of implementation sciences. I would love to hear from researchers who would like to consult about research on disseminating practices recommended in the guidelines to clinical settings. I am also open to early-stage discussions to solidify research concepts.
To date, I have been working on evidence building using large-scale epidemiological data in the fields of psycho-oncology, public health, and health behavior. In particular, I have conducted research on the association between cancer and psychosocial factors, and their effect on the health of cancer patients and their spouses. From an epidemiological perspective, understanding the “true association” plays an important role. I would like to investigate these matters to ensure that research outcomes focused on the epidemiological perspective are broadly returned to society.
I have been involved in research on supportive care while providing guidance for medication as a pharmacist. I am particularly interested in countermeasures for the nausea and vomiting caused by anticancer drug therapy. I am working to incorporate the perspectives of a pharmacist to research, including adjusting medication timing depending on drug characteristics.
I believe that having passion and like-minded colleagues who make you think, “I want to conduct research with these people,” is the most important thing for resolving questions of “why” encountered in clinical practice. I am open to consultation from the planning stage. I look forward to peers who would like to conduct research with us that will benefit patients and their families.
I am in charge of the Supportive and Palliative Care group. When you think about minor questions in day-to-day clinical practice, you realize how little you know about this field of medicine. I want to work on research in supportive and palliative care to resolve minor but important clinical questions, while thinking, worrying, and learning together with everyone.
I am a psychosomatic physician. I would like to contribute to the realization of holistic medicine by specializing in psychosomatic and behavioral medicine.
I look forward to supporting your research.
Thank you very much for your cooperation.